FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.
about
Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsGenomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsFGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.The Fibroblast Growth Factor signaling pathwayFGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal CarcinomaSubpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen responseTargeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Roles of FGFR in oral carcinogenesis.Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer.Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility.High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.A new bright-field dual-colour chromogenic and silver in situ hybridization method for the detection of FGFR1 gene copy number status.Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
P2860
Q26801718-02EA972C-6599-4BAC-A684-EF35BFEF4068Q26998790-AA570C8D-E406-493E-A826-EE3A73099F97Q27853055-382BC0BC-0C18-4631-9AB5-B6BB10B41B11Q27853061-D93B8C23-0494-4031-8FD5-9A50DB9282CCQ34467171-E2417EB8-DCD3-4C4A-812E-642E2B1F28D3Q35837391-3A3C1C17-B0DB-4063-B51E-02EE599260E5Q36715181-EEAC530B-7283-4F06-93A6-AEE4CC255CB7Q37639160-D6FF0011-93A5-4C7C-AF5A-F027BE42C8B9Q38212165-348BDB11-0280-44D9-9F92-CBAB54123B99Q38842890-E08412CD-CE09-4E7B-B04D-421A994862C6Q38887905-753A8310-EA6D-4319-B3FF-3870ED9DC838Q46632048-7350D0A5-04EE-4EE3-B26E-BB48E93C2FE4Q47141559-7C384595-C76C-4B74-B29D-26E3274A8022Q49887925-726D8B46-EC96-4D94-95D8-B0B5E5E80668Q54373997-8893556F-BE7D-4778-9119-76ECD4F5D5B8Q57109523-7E0D1A8A-9DF0-4D56-A29D-73A8F2EFC861
P2860
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
FGFR-1 amplification in metast ...... nous lobular breast carcinoma.
@ast
FGFR-1 amplification in metast ...... nous lobular breast carcinoma.
@en
type
label
FGFR-1 amplification in metast ...... nous lobular breast carcinoma.
@ast
FGFR-1 amplification in metast ...... nous lobular breast carcinoma.
@en
prefLabel
FGFR-1 amplification in metast ...... nous lobular breast carcinoma.
@ast
FGFR-1 amplification in metast ...... nous lobular breast carcinoma.
@en
P2093
P2860
P50
P356
P1476
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
@en
P2093
Annamaria Molino
Eleonora Brunello
Franco Bonetti
Giuseppe Bogina
Guido Martignoni
Keith Miller
Marco Chilosi
Marco Vergine
Matteo Brunelli
Serena Pedron
P2860
P2888
P356
10.1186/1756-9966-31-103
P50
P577
2012-12-27T00:00:00Z
P5875
P6179
1052188580